title: Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists.
abstract: To identify symptoms and risk factors associated with Helicobacter pylori infection, a cohort of 341 epidemiologists was studied. All subjects had one banked serum (collected between 1969 and 1987) and one recent serum sample (collected in 1988) evaluated for H. pylori immunoglobulin G by enzyme-linked immunosorbent assay; subjects provided information on gastrointestinal symptoms and risk factors for gastritis and peptic ulcer disease. Prevalence of infection decreased from the early 1970s to the present. Eleven subjects (3% of the total cohort) seroconverted during the interval between serum samples, giving a crude conversion rate of 0.49% per person-year (95% confidence interval, 0.3-0.9). Nonreactors on the 1988 serum sample described similar symptoms to reactors. However, subjects who seroconverted in the interval between the two serum samples were more likely than either persistent nonreactors [relative risk (RR), 4.1] or persistent reactors (RR, 3.7) to have experienced upper gastrointestinal symptoms in the interval years. Consumption of caffeinated beverages (RR, 4.6) and residence in the northeastern United States (RR, 5.3) seemed to increase risk for infection. Because pain was similarly common in H. pylori-positive and -negative patients, H. pylori cannot be summarily accepted as the cause of dyspeptic symptoms even when infection is confirmed.
authors.affiliation: Division of Bacterial Diseases, Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia.
authors.forename: J
authors.initials: J
authors.lastname: Parsonnet
authors.forename: M J
authors.initials: MJ
authors.lastname: Blaser
authors.forename: G I
authors.initials: GI
authors.lastname: Perez-Perez
authors.forename: N
authors.initials: N
authors.lastname: Hargrett-Bean
authors.forename: R V
authors.initials: RV
authors.lastname: Tauxe
mesh_terms: D000328:Adult; D000367:Age Factors; D000907:Antibodies, Bacterial / Q000032:analysis; D015331:Cohort Studies; D004797:Enzyme-Linked Immunosorbent Assay; D004813:Epidemiology; D005260:Female; D016481:Helicobacter Infections / Q000453:epidemiology* / Q000209:etiology / Q000276:immunology; D016480:Helicobacter pylori / Q000276:immunology; D006801:Humans; D008297:Male; D010820:Physicians; D015995:Prevalence; D012307:Risk Factors; D012737:Sex Factors
chemical_list: D000907:Antibodies, Bacterial